Antivirals and neutralising Monoclonal Antibodies (nMABs) for COVID-19

Clinical therapies for patients with hospital onset COVID-19 infection


Please note: Although intravenous remdesivir is included in the guidance, this drug is not available for delivery in the community setting in NHS Highland. An update on the use of remdesivir within current NICE Guidance is awaited, pending an appeal by the manufacturer.


Please note: Due to concerns over the efficacy of sotrovimab against the current circulating Omicron variants of SARS-CoV-2 (BA.2 and others), sotrovimab is not currently being offered routinely.  Please discuss any individual patient requirements with one of the Infectious Diseases consultants.